Clinical trials sponsored by Daewoong Pharmaceutical Co. LTD.

3

Recruiting trials

6

Conditions studied

Phase breakdown

Phase 1 1Not applicable 2

Conditions studied

Condition	Trials
Hypertension	2
Type 2 Diabetes	2
Diabetes Mellitus, Type 2	1
Obesity	1
Obesity & Overweight	1
Stage 1 Hypertension	1

Recruiting trials led by Daewoong Pharmaceutical Co. LTD.

A Phase 1 Clinical Trial to Assess the Safety of DWRX5003 and Relative Bioavailability to DWC202502 and DWC202503 in Healthy Adult Volunteers
NCT07539415 · Phase: Phase 1 · Ages: 19 Years to 64 Years · Sex: All (male and female) · 1 location
Evaluation of Enavogliflozin's Efficacy and Safety in Type II Diabetes With Hypertension or Dyslipidemia
NCT06647888 · Phase: Not specified · Ages: 19 Years and older · Sex: All (male and female) · 2 locations
Observational Study to Evaluate the Efficacy of OLMETEC Tab on Nocturnal Blood Pressure Control in Patients With Stage Ⅰ Hypertension
NCT07515599 · Phase: Not specified · Ages: 19 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials is Daewoong Pharmaceutical Co. LTD. recruiting for?

Daewoong Pharmaceutical Co. LTD. is the lead sponsor of 3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.